Effects of Pharmaceutical Exposures Ian Wilson

Similar documents
THE HUMAN MICROBIOME: RECENT DISCOVERIES AND APPLICATIONS TO MEDICINE

SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K CURRENT REPORT

Human-microbe mutualism: stability and resilience in health and disease

The Human Microbiome Project : Implications for Probiotics

Microbiota: Agents for Health and Disease Dr. B. Brett Finlay

Patentability/Literature Research

Mini-Symposium MICROBIOTA. Free. Meet the speaker. 14. November :30 19:00 Bohnenkamp Haus. Everyone welcome. Sponsored by:

Metagenomics Advanced Topics in Computa8onal Genomics

John F. Kokai-Kun Digestive Disease Week Chicago, IL May 9, 2017

Factors Affecting the Composition of the Laboratory Mouse Microbiome. Aaron C. Ericsson, DVM, PhD HESI Microbiome Workshop June 26, 2018

Mice as Translational Models: Planning a Fecal Microbiota Transplantation Study

Trust Yours. Protect Theirs.

Microbiota and What the Clinical Gastroenterologist Needs to Know

CONSIDERING THE MICROBIOME AS PART OF FUTURE MEDICINE AND NUTRITION STRATEGIES: Challenges and proposed answers

VICH Topic GL36 STUDIES TO EVALUATE THE SAFETY OF RESIDUES OF VETERINARY DRUGS IN HUMAN FOOD: GENERAL APPROACH TO ESTABLISH A MICROBIOLOGICAL ADI

A new vision for AMR innovation to support medical care

Customized Phage Therapies To Eradicate Harmful Bacteria In Chronic Diseases. Europe Microbiome Congress London, 14 Nov., 2018

Companion Diagnostics in Autoimmune Disorders: Improving Outcomes Through Personalized Medicine

STABILITY OF INTESTINAL TRACT MICROFLORA AS DETERMINED BY TRF PATTERN ANALYSIS OF 16S RIBOSOMAL RNA GENE. By Catherine Houchen-Wise

UNITING AGRICULTURE AND MEDICINE. Director, Nebraska Food for Health Center

METAGENOMICS. Aina Maria Mas Calafell Genomics

SYN-004 (ribaxamase) prevents New Onset Clostridium difficile Infection by Protecting the Integrity Gut Microbiome in a Phase 2b Study

Microbial Community Assembly and Dynamics:.from AMD biofilms to colonization of the premature infant gut

Fecal transplant: Con Position

Bringing True Novelty to the Anti-Infective Space

UK AMR Diagnostics Collaborative:

Providing clear solutions to microbiological challenges TM. cgmp/iso CLIA. Polyphasic Microbial Identification & DNA Fingerprinting

ONAMER M. PRESERVATIVE and ANTIMICROBIAL ONAMER

Metagenomics Computational Genomics

Assembly Biosciences Jefferies 2015 Microbiome Summit. December 16, 2015

Drug Development in Inflammatory Bowel Disease: The FDA Perspective

The Gut Microbiome: Where to look for Biomarkers

PROVIDING ADAPTED TECHNOLOGICAL INNOVATION SOLUTIONS

Conducting Microbiome study, a How to guide

Human Microbiome Project: First Map of the World Within Us. Hsin-Jung Joyce Wu "Microbiota and man: the story about us

Elena BM Breidenstein, PhD 21 April 2018

USB Project Report 1. SUB/CONTRACTOR INFORMATION 2. PROJECT INFORMATION Principal Investigator Name: Bridget Owen

Webinar 9 Part 1. ProVen: Microbiota

Enabling the adoption of new diagnostics within the UK healthcare system:

An introduction into 16S rrna gene sequencing analysis. Stefan Boers

Combatting Antibiotic Resistant Bacteria (CARB) The Need for Data - The USDA Perspective

Abstract. Introduction

May Microbiome Modulation. Assaf Oron, CBO Biomed Conference Tel Aviv, May 2017

From Discovery to Development of new Drugs. and pitfalls along the way. by Kim Dekermendjian, PhD in Medicine BD & Key Account manager

The Microbiology of Food

Probiotic and Prebiotic Definitions: Where do we stand?

Kumamoto Isberg Lee. Van Deventer. Tzanakakis

Mechanisms and Pathways of AMR in the Environment

REPORT DOCUMENTATION PAGE (SF298) (Continuation Sheet) DARPA BAA03-02 Proposal: Analysis of GI community shifts in response to dietary fiber

Discovery of Bacterial Effectors in the Human Microbiome and Isolation of a GPCR G2A/GPR132 Agonist

The role of PHE s AMRHAI Reference Unit

Have you wondered why it is called: a gut feeling or a gut instinct?

The University of Jordan

Role of PBPK based virtual trials modeling in generic product development and regulation

Antimicrobial resistance: environments, evolution and transmission. Workshop series summary

BSc Minors in English

ECO-PHARMACO- STEWARDSHIP (EPS) PILLAR 1 - RESEARCH & DEVELOPMENT: INTELLIGENCE-LED ASSESSMENT OF PHARMACEUTICALS IN THE ENVIRONMENT (ipie)

PROFESSIONAL ETHICS, LEADERSHIP AND INTEGRITY: WHAT DOES IT MATTER HOW OUR RESEARCH IS USED? Suzanne Hendrich, PhD University Professor FSHN

Biotech Applications Nucleic acid therapeutics, Antibiotics, Transgenics. BIT 220 End of Chapter 22 (Snustad/Simmons)

Guideline on the Nonclinical Safety Study in Juvenile Animals for Pediatric Drugs. Table of Contents

Metagenomics in Medicine Towards Disease early Diagnosis and Personalized Treatment

Developing Novel Treatments for Autoimmune Diseases

SYMBIOTIC HEALTH. Targeted GI Delivery of Orally Administered Cells and Proteins for Microbiome-Based Therapeutics

Hector R. Wong, MD Division of Critical Care Medicine Cincinnati Children s Hospital Medical Center Cincinnati Children s Research Foundation

Yesterday s Picture UNIT 3E

Etienne Ruppé AP HP, Hôpital Bichat Claude Bernard UMR 1137 IAME

For personal use only. Annual General Meeting 13 November 2017

Effect of Diuresis on Staphylococcus aureus Kidney

Chemical Control Methods. Chemotherapy

Comparative genomics of clinical isolates of Pseudomonas fluorescens, including the discovery of a novel disease-associated subclade.

Electronic Supplementary Information

VICH GL36(R): Studies to evaluate the safety of residues of veterinary drugs in human food: general approach to establish a microbiological ADI

BASICS OF EXPERIMENTAL PHARMACOLOGY

Antibiotic Resistance Genes: From The Farm To The Human Gut

DEPARTMENT: MICROBIOLOGY PROGRAMME: B SC. Statements of Programme Specific Outcomes (PSOs)

ICH Topic E16 Genomic Biomarkers Related to Drug Response: Context, Structure and Format of Qualification Submissions. Step 3

Translational Research

Biomarkers: Physiological & Laboratory Markers of Drug Effect

BA, BSc, and MSc Degree Examinations

Biomarkers: Physiological & Laboratory Markers of Drug Effect

Goals of pharmacogenomics

Drug Development: Why Does it Cost so Much? Lewis J. Smith, MD Professor of Medicine Director, Center for Clinical Research Associate VP for Research

How do drugs work? Part 1. PK: Principles & Processes. PK vs. PD. Pharmacokinetics : Basic Principles Overview. What does the body do to a drug?

Royal Society of Chemistry Response to the House of Commons Science and Technology Committee Call For Evidence: Antimicrobial Resistance

March Company Introduction. Microbiome R&D and Business Collaboration Forum: Europe Myriam Golembo, VP Development

Gastrointestinal Devices for Long-Term In Situ Delivery of Therapeutic Microbes

Laura Andrews, PhD, DABT, Fellow ATS

Polypharmacology. Giulio Rastelli Molecular Modelling and Drug Design Lab

This training module covers the following animals housed in vivaria: rodents rabbits birds amphibians reptiles non-human primates other mammals

Subcommittee on Distinguishing Adverse from Non-Adverse and Adaptive Effects

The role of genomics in the development of new and improved therapies

APX001 is effective against echinocandin and multidrug resistant Candida isolates

December 19-20, th Street NW, Washington DC National Academies of Sciences, Engineering, and Medicine Keck Center, Room 100

Supplementary Figure and Table Legends

OMICS Group. Contact us at:

Biology 123 Microbiology Summer 2015

Session 3 Lecture 1 Dynamics of the GIT Microbiome: Microbial Darwinism

Jianguo (Jeff) Xia, Assistant Professor McGill University, Quebec Canada June 26, 2017

Promise and Pitfalls of MicrobiomeModulating Methods for Inflammatory

Transcription:

Effects of Pharmaceutical Exposures Ian Wilson Imperial College London

Questions Can pharmaceuticals (drugs) at therapeutic doses affect the gut microbiome? If yes, are there consequences for the host? Is there evidence that environmental drug exposures act directly on the human gut microbiome? What about the impact on human microbiomes of agricultural drug use? What about indirect effects?

Background The gut microbiomes provide the host with an important external organ with significant metabolic capacity and the microbiota that form it are not passengers but crew. Environmental factors exert a major influence in the development and evolution of an individuals microbiome. Initially the microbiome is derived from the mother but subsequent exposures to chemicals (including drugs) and environmental microoganisms can modify it. The presence of the gut microbiome has direct effects on the host and changes the hosts metabolic profile

What else affects the microbiome? Age Genetics Sex Diet Disease Etc. etc, all of which might represent confounding factors

How Does the Microbiome affect the Host Metabolic Phenotype? Proton NMR Spectrum of Normal Rat Urine 8.5 8.0 7.5 7.0 6.5 ppm 4.0 3.5 3.0 2.5 2.0 1.5 ppm

The Absence of a Microbiome Proton NMR Spectrum of Urine from a Germ-Free Rat Low aromatics and high formic acid compared to normal rats 8.5 8.0 7.5 7.0 6.5 ppm 4.0 3.5 3.0 2.5 2.0 1.5 ppm

So What Effect Does Host Genetics Have? Genetic differences reasonably might be expected to have effects on the composition of the microbiome? Examination of the fecal microbiome of a number of strains of mouse seems to show that different bacterial composition is associated with the different genetic backgrounds

Dice (Opt:0.50%) (Tol 1.3%-1.3%) (H>0.0% S>0.0%) [0.0%-100.0%] different mouse strains with scid 6 Different strains of mice 6 different microbiomes 50 55 60 65 70 75 80 85 90 95 100 Friswell MK, PLoS ONE 5(1): e8584. doi:10.1371/journal.pone.0008584 CD1 (1) CD1 (2) CD1 (3) CD1 (4) CD1 (5) GFEC (3) GFEC (4) GFEC (1) GFEC (2) C57 (2) C57 (3) C57 (1) CBA (1) CBA (2) CBA (4) CBA (5) CBA (6) CBA (3) C3H (1) C3H (2) C3H (3) SCID (1) SCID (2) SCID (3)

Strain vs Environmental Effects on the Microbiome The results for the different strains look fairly unequivocal but. What about the fact that they were brought up in different cages and had different mothers? Will these factors also affect the resulting microbiome (and the metabolic phenotype)?

Maternal vs Strain Effects on the Micobiome Pearson correlation [0.0%-100.0%] foster mum strains (2 genders) and 1 mother 93 94 95 96 97 98 99 100 AG 3 (5) C57 4 (5) 300000 AG 2 (5) C57 1 (5) C57 6 (4) AG 5 (4) C57 4 (4) 200000 AG 2 (4) C57 1 (4) AG 3 (4) AG 5 (5) 100000 C57 6 (5) C57 1 (1) C57 4 (2) C57 6 (2) 0 AG 3 (1) AG 5 (2) AG 5 (1) C57 4 (1) -100000 C57 6 (1) BDF1. (1) AG 3 (2) C57 1 (2) -200000 AG 2 (1) AG 2 (2) AG 2 (3) C57 1 (3) -300000 AG 3 (3) C57 4 (3) C57 6 (3) AG 5 (3) C57 Agoutie Male Female -400000-200000 0 200000 400000 SIMCA-P+ 11-11/10/2007 09:59:16 R2X 0.822, Q2(cum) 0.545 So, for mice, the maternal environment is more important than strain, and so is gender, Friswell MK, PLoS ONE 5(1): e8584. doi:10.1371/journal.pone.0008584

Age-Related Effects on Mice of Changing Environments For mice the environment is more important than the maternal environment Microbiome Pearson correlation [0.0%-100.0%] Moved mature mice (a) 60 65 70 75 80 85 90 95 100 C3H 7 C (2) C3H 8 C (2) C3H 6 B (2) C3H 4 B (2) C3H 5 B (2) C3H 9 C (2) C3H 6 B (4) C3H 7 C (3) C3H 8 C (4) C3H 4 B (4) C3H 5 B (4) C3H 8 C (1) C3H 9 C (1) C3H 5 B (1) C3H 4 B (1) C3H 7 C (1) C3H 6 B (1) C3H 4 B (3) C3H 5 B (3) C3H 6 B (3) C3H 8 C (3) C3H 9 C (3) C3H 9 C (4) C3H 1 A (5) C3H 2 A (5) C3H 3 A (5) C3H 2 A (6) C3H 3 A (6) C3H 1 A (6) C3H 2 A (2) C3H 3 A (2) C3H 1 A (2) C3H 1 A (3) C3H 1 A (1) C3H 2 A (3) C3H 3 A (3) C3H 2 A (4) C3H 3 A (4) C3H 1 A (4) C3H 2 A (1) C3H 3 A (1) (b) Host metabolic phenotype SIMCA-P+ 11-21/08/2007 19:10:06 The Metabolic Phenotype Reflects Microbiotype Friswell MK, PLoS ONE 5(1): e8584. doi:10.1371/journal.pone.0008584

The Environment and the Rat Microbiome 3 strains of Zucker rat: 3 animals, 1 of each strain, housed in each of 6 cages

Effects of Antibiotic s on the Rat 3 groups of rats 6 Control Rats 6 Antibiotic treated 8 days 6 Antibiotic treated - 4 days then allowed to recover Swann et al PNAS 2011 vol. 108 suppl. 1 4523 4530 13

14 Swann et al PNAS 2011 vol. 108 suppl. 1 4523 4530

Can Pharmaceuticals (drugs) at Therapeutic Doses Affect the Human Gut Microbiome? Antibiotics are obvious candidates. They can clearly directly affect the microbiomes Proton Pump Inhibitors (PPI s), their pharmacology changes the gut environment Non-steroidal anti-inflammatory drugs (NSAID s) can cause gut damage and this results in changes to the gut environment

Antibiotics: Effects On The Microbiome Jernberg et al, (2010)Long-term impacts of antibiotic exposure on the human intestinal microbiota, Microbiology, 156, 3216 3223 (A REVIEW) Dethlefsen et al (2008) The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rrna sequencing. PLoS Biol 6(11): e280. Dethlefsen & Relman ( 2011) Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation PNAS, 108, 4554 4561, suppl. 1

Effects of PPI s On The Microbiome Lo & Chan, (2013) Proton Pump Inhibitor Use and the Risk of Small Intestinal Bacterial Overgrowth: A Meta-analysis, Clin. Gastroenterology & Hepatology 11:483-490 Freedberg et al (2014) The impact of proton pump inhibitors on the human gastrointestinal microbiome, Clin Lab Med. 34, 771 785 Marlicz et al (2014 ) Nonsteroidal Anti-inflammatory Drugs, Proton Pump Inhibitors, and Gastrointestinal Injury: Contrasting Interactions in the Stomach and Small Intestine, Mayo Clin Proc. 89,1699-1709 Imhann et al (2015) Proton pump inhibitors affect the gut microbiome, Gut;0:1 9.

Are There Consequences of Drug Induced Microbiome Changes for the Host? Antibiotics, Proton Pump Inhibitors (PPI s) and Non-steroidal anti-inflammatory drugs (NSAID s) have both short and long term effects on the microbiome. Probably ANY drug that acts on the gut microbiota, or directly or indirectly affects the physiology of the gut, has the potential to modify the microbiome.

What about environmental exposure to drugs? Environmental contamination of e.g., potable water by antibiotics is typically fairly low well below any likely major direct effects. However, local concentrations in waste water or effluent in some areas due to manufacturing waste do have concentration of antibiotics that exceed those expected in therapeutic use. Indirect effects are likely to be as a result of stimulating some level of antimicrobial resistance (AMR) giving some species an opportunistic advantage in colonizing the host Agricultural use probably represents a bigger source of affects on the gut microbiome through production of antibiotic-resistant strains

Agricultural use of Antibiotics THE UK REVIEW ON ANTIMICROBIAL RESISTANCE CHAIRED BY JIM O NEILL DECEMBER 2015 ANTIMICROBIALS IN AGRICULTURE AND THE ENVIRONMENT: REDUCING UNNECESSARY USE AND WASTE The Review on AMR, commissioned by the British Prime Minister, and hosted by the Wellcome Trust. It is tasked with recommending, by the summer of 2016, a comprehensive package of actions to tackle AMR globally. In the meantime, they are publishing a series of papers looking at individual aspects of the wider AMR problem.

THE UK REVIEW ON ANTIMICROBIAL RESISTANCE Of 139 academic studies the Review found, only seven (5%) argued that there was no link between antibiotic consumption in animals and resistance in humans, while 100 (72 %) found evidence of a link. According to the figures in this report 70% (8,893,103kg!) of the antibiotic use in the US is in agriculture compared to 30% for humans Of the 41 antimicrobials that were authorised for sale in animals, and sold in the US in 2012, 31 are currently deemed by the FDA to be important for human health.

Consequences The gut microbiome is an important organ of DRUG METABOLISM and can modify drug TOXICITY Changes in the composition of the microbiome could well modify how drugs are metabolised This might affect both efficacy and toxicity An example of this is seen for humans for acetaminophen where competition for sulfation between bacteriallyderived phenols and the drug alters the overall metabolic fate

Tyrosine to p-cresol sulfate Host metabolism of p-cresol to sulfate Microbiome metabolism of tyrosine to p-cresol 4-cresyl sulfate (4CS) Sulfation is a high specificity, but low capacity, preferred route of metabolism for phenols

Paracetamol/ acetaminophen Pre-dose 4-cresyl sulfate / creatinine Changes in 4-cresol production has the potential to impact on host xenobiotic metabolism via competition for sufation

When host sulfation and glucuronidation capacity begins to become limiting then other metabolic routs become more important with consequences for toxicity APAP

Drug-Microbiome Interactions Some Concluding Comments The gut microbiota represents both a major forgotten organ of drug metabolism, activating certain prodrugs, and a target for collateral damage from therapeutic use. Microbes produce waste products to be dealt with by the host and these might affect the efficacy and toxicity for drugs Effects of environmental exposure to sub-therapeutic doses could be quite difficult to show because of all the confounding factors The effect of the presence in the environment of AMR bacteria, capable of colonizing the GI tracts of humans with unwanted consequences, is clear.